545 related articles for article (PubMed ID: 9507224)
1. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
2. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
[TBL] [Abstract][Full Text] [Related]
4. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
[TBL] [Abstract][Full Text] [Related]
5. Identification of post-transplant anti-alpha 5 (IV) collagen alloantibodies in X-linked Alport syndrome.
Dehan P; Van den Heuvel LP; Smeets HJ; Tryggvason K; Foidart JM
Nephrol Dial Transplant; 1996 Oct; 11(10):1983-8. PubMed ID: 8918711
[TBL] [Abstract][Full Text] [Related]
6. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
[TBL] [Abstract][Full Text] [Related]
7. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG
Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274
[TBL] [Abstract][Full Text] [Related]
8. Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis.
Olaru F; Luo W; Wang XP; Ge L; Hertz JM; Kashtan CE; Sado Y; Segal Y; Hudson BG; Borza DB
J Am Soc Nephrol; 2013 May; 24(6):889-95. PubMed ID: 23620401
[TBL] [Abstract][Full Text] [Related]
9. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
10. Retransplantation in Alport post-transplant anti-GBM disease.
Browne G; Brown PA; Tomson CR; Fleming S; Allen A; Herriot R; Pusey CD; Rees AJ; Turner AN
Kidney Int; 2004 Feb; 65(2):675-81. PubMed ID: 14717941
[TBL] [Abstract][Full Text] [Related]
11. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
12. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen.
Sado Y; Boutaud A; Kagawa M; Naito I; Ninomiya Y; Hudson BG
Kidney Int; 1998 Mar; 53(3):664-71. PubMed ID: 9507212
[TBL] [Abstract][Full Text] [Related]
13. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS; Baumal R; Eddy A; Marrano P
Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
[TBL] [Abstract][Full Text] [Related]
16. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
17. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical studies of the Alport antigen.
Kleppel MM; Fan WW; Cheong HI; Kashtan CE; Michael AF
Kidney Int; 1992 Jun; 41(6):1629-37. PubMed ID: 1501419
[TBL] [Abstract][Full Text] [Related]
19. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
[TBL] [Abstract][Full Text] [Related]
20. Production of anti-NC1 antibody by affected male dogs with X-linked hereditary nephritis: a probe for assessing the NC1 domain of collagen type IV in dogs and humans with hereditary nephritis.
Thorner PS; Baumal R; Valli VE; Mahuran D; Marrano PM; Jacobs R
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):467-75. PubMed ID: 1466151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
